Gatto L.; Del Gaudio M.; Ravaioli M.; Cescon M.; Tonini V.; Cervellera M.; Franceschelli A.; Pirini M.G.; Di Scioscio V.; Buia F.; Niro F.; Capizzi E.; Fiorentino M.; Astolfi A.; Indio V.; Nannini M.; Pantaleo M.A.; Saponara M., Paratesticular Mesenchymal Malignancies: A Single-Center Case Series, Clinical Management, and Review of Literature, «INTEGRATIVE CANCER THERAPIES», 2020, 19, pp. 1534735419900554 - 1534735419900554 [Scientific article]Open Access
Ambrosi F.; Ricci C.; Malvi D.; De Cillia C.; Ravaioli M.; Fiorentino M.; Cardillo M.; Vasuri F.; D'errico A., Pathological features and outcomes of incidental renal cell carcinoma in candidate solid organ donors, «KIDNEY RESEARCH AND CLINICAL PRACTICE», 2020, 39, pp. 487 - 494 [Scientific article]Open Access
Bianchi L, Schiavina R, Borghesi M, Casablanca C, Chessa F, Mineo Bianchi F, Pultrone C, Vagnoni V, Ercolino A, Dababneh H, Fiorentino M, Brunocilla E, Patterns of positive surgical margins after open radical prostatectomy and their association with clinical recurrence, «MINERVA UROLOGICA E NEFROLOGICA», 2020, 72, pp. 464 - 473 [Scientific article]
Vasuri, F.; Nerpiti, A.; Zagnoni, S.; Ravaioli, M.; D'Errico, A.; Fiorentino, M., Pd-ligand 1 is expressed in inflammatory cells but not in neoplastic cells in hepatocellular carcinoma: An immunohistochemical study, «ACTA HISTOCHEMICA», 2020, 122, Article number: 151468 , pp. 1 - 4 [Scientific article]
Carlsson J.; Sundqvist P.; Kosuta V.; Falt A.; Giunchi F.; Fiorentino M.; Davidsson S., PD-L1 Expression is Associated with Poor Prognosis in Renal Cell Carcinoma, «APPLIED IMMUNOHISTOCHEMISTRY AND MOLECULAR MORPHOLOGY», 2020, 28, pp. 213 - 220 [Scientific article]
Junker, Kerstin; Eckstein, Markus; Fiorentino, Michelangelo; Montironi, Rodolfo, PD1/PD-L1 axis in uro-oncology, «CURRENT DRUG TARGETS», 2020, 21, pp. 1 - 1 [Scientific article]
Cavazzoni A.; Digiacomo G.; Alfieri R.; La Monica S.; Fumarola C.; Galetti M.; Bonelli M.; Cretella D.; Barili V.; Zecca A.; Giovannetti E.; Fiorentino M.; Tiseo M.; Petronini P.G.; Ardizzoni A., Pemetrexed enhances membrane PD-L1 expression and potentiates T cell-mediated cytotoxicity by anti-PD-L1 antibody therapy in non-small-cell lung cancer, «CANCERS», 2020, 12, Article number: 666 , pp. 1 - 16 [Scientific article]Open Access
Trisolini R.; Cancellieri A.; Livi V.; Annema J.T.; Ferrari M.; Natali F.; Paioli D.; Conci N.; Altimari A.; Fiorentino M.; Ardizzoni A., Pulmonary adenocarcinoma with psammoma bodies is associated with a specific endobronchial ultrasound pattern and a high prevalence of actionable driver mutations, «LUNG CANCER», 2020, 147, pp. 204 - 208 [Scientific article]
Ricci C.; Capizzi E.; Giunchi F.; Casolari L.; Gelsomino F.; Rihawi K.; Natali F.; Livi V.; Trisolini R.; Fiorentino M.; Ardizzoni A., Reliability of programmed death ligand 1 (PD-L1) tumor proportion score (TPS) on cytological smears in advanced non-small cell lung cancer: a prospective validation study, «THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY», 2020, 12, Article number: 1758835920954802 , pp. 1 - 8 [Scientific article]Open Access
Droghetti, Matteo; Ercolino, Amelio; Piazza, Pietro; Bianchi, Lorenzo; Fabbrizio, Benedetta; Giunchi, Francesca; Mineo Bianchi, Federico; Barbaresi, Umberto; Casablanca, Carlo; Tonin, Elena; Mottaran, Angelo; Fiorentino, Michelangelo; Schiavina, Riccardo; Brunocilla, Eugenio, Secondary bladder amyloidosis due to Crohn's disease: a case report and literature review, «CEN CASE REPORTS», 2020, 9, pp. 413 - 417 [Scientific article]
Giunchi F.; Franceschini T.; Gruppioni E.; Altimari A.; Capizzi E.; Massari F.; Schiavina R.; Brunelli M.; Martignoni G.; Fiorentino M., Similarities and differences between clear cell tubulo-papillary and conventional clear cell renal cell carcinoma: A comparative phenotypical and mutational analysis, «DIAGNOSTICS», 2020, 10, Article number: 123 , pp. 123 - 123 [Scientific article]Open Access
Giunchi, Francesca; Gevaert, Thomas; Scarpelli, Marina; Fiorentino, Michelangelo, Status of Programmed Death Ligand 1 (PD-L1) by immunohistochemistry and scoring algorithms, «CURRENT DRUG TARGETS», 2020, 21, pp. 1 - 1 [Scientific article]
Stopsack K.H.; Gerke T.; Zareba P.; Pettersson A.; Chowdhury D.; Ebot E.M.; Flavin R.; Finn S.; Kantoff P.W.; Stampfer M.J.; Loda M.; Fiorentino M.; Mucci L.A., Tumor protein expression of the DNA repair gene BRCA1 and lethal prostate cancer, «CARCINOGENESIS», 2020, 41, pp. 904 - 908 [Scientific article]
Bianchi L, Schiavina R, Borghesi M, Chessa F, Casablanca C, Angiolini A, Ercolino A, Pultrone CV, Mineo Bianchi F, Barbaresi U, Piazza P, Manferrari F, Bertaccini A, Fiorentino M, Ferro M, Porreca A, Marcelli E, Brunocilla E, Which patients with clinical localized renal mass would achieve the trifecta after partial nephrectomy? The impact of surgical technique, «MINERVA UROLOGICA E NEFROLOGICA», 2020, 72, pp. 339 - 349 [Scientific article]Open Access
Di Nunno V, Mollica V, Brunelli M, Gatto L, Schiavina R, Fiorentino M, Santoni M, Montironi R, Caliò A, Eccher A, Milella M, Martignoni G, Brunocilla E, Massari F, A Meta-Analysis Evaluating Clinical Outcomes of Patients with Renal Cell Carcinoma Harboring Chromosome 9P Loss., «MOLECULAR DIAGNOSIS & THERAPY», 2019, 23, pp. 569 - 577 [Scientific article]
